The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering

Current Stem Cell Research and Therapy

Volumn 2, Issue 3, 2007, Pages 209-220

  Siddappa, Ramakrishnaiah ^a   Fernandes, Hugo ^a   Liu, Jun ^a   van Blitterswijk, Clemens ^a   de Boer, Jan ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Bone tissue engineering; Heterogeneity; Human mesenchymal stem cells; Osteoblast differentiation; Signaling pathways; Species differences

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CYCLIC AMP; DEXAMETHASONE; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TRICHOSTATIN A; VITAMIN D; WNT PROTEIN;

BONE DEFECT; BONE DEVELOPMENT; BONE INJURY; BONE REMODELING; BONE TISSUE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL SPECIFICITY; CORTICOSTEROID INDUCED OSTEOPOROSIS; FRAGILITY FRACTURE; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOBLAST; OSTEOPENIA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SPINE FUSION; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

EID: 34848895917     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488807781696267     Document Type: Review

References (130)

1. Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999; 354 (Suppl 1): S132-4.
2. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-6.
3. Carlson ER, Marx RE, Buck BE. The potential for HIV transmission through allogeneic bone. A review of risks and safety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 17-23.
4. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 2002; 84-A: 716-20.
5. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996: 300-9.
6. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284; 143-7.
7. Dezawa M, Ishikawa H, Itokazu Y, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005; 309: 314-7.
8. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974; 17: 331-40.
9. Khosla S, Eghbali-Fatourechi GZ. Circulating cells with osteogenic potential. Ann N Y Acad Sci 2006; 1068: 489-97.
10. Bellows CG, Aubin JE. Determination of numbers of osteoprogenitor: present in isolated fetal rat calvaria cells in vitro. Dev Biol 1989; 133: 8-13.
11. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004; 22: 560-7.
12. Oreffo RO, Bord S, Triffitt JT. Skeletal progenitor cells and ageing human populations. Clin Sci (Lond) 1998; 94: 549-55.
13. Miao Z, Jin J, Chen L, et al. Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 2006; 30: 681-7.
14. Derubeis AR, Cancedda R. Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng 2004; 32: 160-5.
15. Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA. Cell-Based Bone Tissue Engineering. PLoS Med 2007; 4: e9.
16. Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18: 959-63.
17. Solchaga LA, Johnstone B, Yoo JU, Goldberg VM, Caplan AI. High variability in rabbit bone marrow-derived mesenchymal cell preparations. Cell Transplant 1999; 8: 511-9.
18. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994; 84: 4164-73.
19. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992; 13: 69-80.
20. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997; 21: 225-35.
21. Gronthos S, Zannettino AC, Hay SJ, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003; 116: 1827-35.
22. Brendel C, Kuklick L, Hartmann O, et al. Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genes. Gene Expr 2005; 12: 245-57.
23. Pereira RF, Halford KW, O'Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995; 92: 4857-61.
24. van Straalen JP, Sanders E, Prummel MF, Sanders GT. Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta 1991; 201: 27-33.
25. Boer JD, Licht R, Bongers M, et al. Inhibition of Histone Acetylation as a Tool in Bone Tissue Engineering. Tissue Eng 2006.
26. Heng BC, Cao T, Stanton LW, Robson P, Olsen B. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res 2004; 19: 1379-94.
27. Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res 2003; 44 (Suppl 1): 305-11.
28. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29.
29. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997; 64: 295-312.
30. Siddappa R, Licht, R., Van Blitterswijk, C and de Boer, J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 2007; In press.
31. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 1998; 93: 487-90.
32. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 2002; 22: 7802-11.
33. Saklatvala J. Glucocorticoids: do we know how they work? Arthritis Res 2002; 4: 140-50.
34. Adcock IM. Glueocorticoid-regulated transcription factors. Pulm Pharmacol Ther 2001; 14: 211-9.
35. Popp AW, Isenegger J, Buergi EM, Buergi U, Lippuner K. Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment. Eur Spine J 2006: 1-15.
36. Liu Y, Titus L, Barghouthi M, et al. Glucocorticoid regulation of human BMP-6 transcription. Bone 2004; 35: 673-81.
37. Dieudonne SC, Kerr JM, Xu T, et al. Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone. J Cell Biochem 1999; 76: 231-43.
38. Williams JT, Southerland SS, Souza J, Calcutt AF, Cartledge RG. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 1999; 65: 22-6.
39. Kim HJ, Zhao H, Kitaura H, et al. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 2006; 116: 2152-60.
40. Ogston N, Harrison AJ, Cheung HF, Ashton BA, Hampson G. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Steroids 2002; 67: 895-906.
41. de Bruijn JD, van den Brink I, Mendes S, et al. Bone induction by implants coated with cultured osteogenic bone marrow cells. Adv Dent Res 1999; 13: 74-81.
42. te Pas MF, de Jong PR, Verburg FJ. Glucocorticoid inhibition of C2C12 proliferation rate and differentiation capacity in relation to mRNA levels of the MRF gene family. Mol Biol Rep 2000; 27: 87-98.
43. Luppen CA, Leclerc N, Noh T, et al. Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem 2003; 278: 44995-5003.
44. Lian JB, Shalhoub V, Aslam F, et al. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 1997; 138: 2117-27.
45. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004; 16: 291-9.
46. Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000; 19: 1745-54.
47. Kale S, Biermann S, Edwards C, et al. Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat Biotechnol 2000; 18: 954-8.
48. Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 2004; 23: 552-63.
49. Moioli EK, Hong L, Guardado J, Clark PA, Mao JJ. Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng 2006; 12: 537-46.
50. Urist MR. Bone: formation by autoinduction. Science 1965; 150: 893-9.
51. Reddi AH. BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev 2005; 16: 249-50.
52. Xiao C, Shim JH, Kluppel M, et al. Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. Genes Dev 2003; 17: 2933-49.
53. Li JZ, Li H, Sasaki T, et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 2003; 10: 1735-43.
54. Lee KS, Kim HJ, Li QL, et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000; 20: 8783-92.
55. Wada MR, Inagawa-Ogashiwa M, Shimizu S, Yasumoto S, Hashimoto N. Generation of different fates from multipotent muscle stem cells. Development 2002; 129: 2987-95.
56. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-54.
57. Miyazono K, Miyazawa K. Id: a target of BMP signaling. Sci STKE 2002; 2002: PE40.
58. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 1999; 274: 19838-45.
59. Cheng H, Jiang W, Phillips FM, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85-A: 1544-52.
60. Edgar AJ, Dover SL, Lodrick MN, et al. Bone morphogenetic protein-2 induces expression of murine zinc finger transcription factor ZNF450. J Cell Biochem 2005; 94: 202-15.
61. Hong JH, Hwang ES, McManus MT, et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005; 309: 1074-8.
62. Baltzer AW, Lieberman JR. Regional gene therapy to enhance bone repair. Gene Ther 2004; 11: 344-50.
63. Huang YC, Simmons C, Kaigler D, Rice KG, Mooney DJ. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein4 (BMP-4). Gene Ther 2005; 12: 418-26.
64. Kang Q, Sun MH, Chong H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004; 11: 1312-20.
65. Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 2006; 98: 538-54.
66. Osyczka AM, Leboy PS. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 2005; 146: 3428-37.
67. Mendes SC, Van Den Brink I, De Bruijn JD, Van Blitterswijk CA. In vivo bone formation by human bone marrow cells: effect of osteogenic culture supplements and cell densities. J Mater Sci Mater Med 1998; 9: 855-8.
68. Kolpakova E, Olsen BR. Wnt/beta-catenin-a canonical tale of cell-fate choice in the vertebrate skeleton. Dev Cell 2005; 8: 626-7.
69. Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest 2006; 116: 1202-9.
70. Boyden LM, Mao J, Belsky J, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002; 346: 1513-21.
71. Bennett CN, Longo KA, Wright WS, et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 2005; 102: 3324-9.
72. Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001; 107: 513-23.
73. Zhou S, Eid K, Glowacki J. Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. J Bone Miner Res 2004; 19: 463-70.
74. De Boer J, Wang HJ, Van Blitterswijk C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 2004; 10: 393-401.
75. Cho HH, Kim YJ, Kim SJ, et al. Endogenous Wnt signaling promotes proliferation and suppresses osteogenic differentiation in human adipose derived stromal cells. Tissue Eng 2006; 12: 111-21.
76. de Boer J, Siddappa R, Gaspar C, et al. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 2004; 34: 818-26.
77. Boland GM, Perkins G, Hall DJ, Tuan RS. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004; 93: 1210-30.
78. Neth P, Ciccarella M, Egea V, et al. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells 2006; 24: 1892-903.
79. Gunn WG, Conley A, Deininger L, et al. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells 2006; 24: 986-91.
80. Gregory CA, Perry AS, Reyes E, et al. Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J Biol Chem 2005; 280: 2309-23.
81. Gregory CA, Gunn WG, Reyes E, et al. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann N Y Acad Sci 2005; 1049: 97-106.
82. Gardella TJ, Juppner H. Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol Metab 2001; 12: 210-7.
83. Wilkie TM, Gilbert DJ, Olsen AS, et al. Evolution of the mammalian G protein alpha subunit multigene family. Nat Genet 1992; 1: 85-91.
84. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984; 308: 693-8.
85. Simonds WF. G protein regulation of adenylate cyclase. Trends Pharmacol Sci 1999; 20: 66-73.
86. Miao D, He B, Karaplis AC, Goltzman D. Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 2002; 109: 1173-82.
87. Karaplis AC, Luz A, Glowacki J, et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994; 8: 277-89.
88. Kuznetsov SA, Riminucci M, Ziran N, et al. The interplay of osteogenesis and hematopoiesis: expression of a constitutively active PTH/PTHrP receptor in osteogenic cells perturbs the establishment of hematopoiesis in bone and of skeletal stem cells in the bone marrow. J Cell Biol 2004; 167: 1113-22.
89. Brommage R, Hotchkiss CE, Lees CJ, et al. Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab, 1999; 84: 3757-63.
90. Schiller PC, D'Ippolito G, Roos BA, Howard GA. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res 1999; 14: 1504-12.
91. Tyson DR, Swarthout JT, Jefcoat SC, Partridge NC. PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity, but not casein kinase II sites. Endocrinology 2002; 143: 674-82.
92. Clohisy JC, Scott DK, Brakenhoff KD, Quinn CO, Partridge NC. Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells. Mol Endocrinol 1992; 6: 1834-42.
93. Koe RC, Clohisy JC, Tyson DR, et al. Parathyroid hormone versus phorbol ester stimulation of activator protein-1 gene family members in rat osteosarcoma cells. Calcif Tissue Int 1997; 61: 52-8.
94. McCauley LK, Koh-Paige AJ, Chen H, et al. Parathyroid hormone stimulates fra-2 expression in osteoblastic cells in vitro and in vivo. Endocrinology 2001; 142: 1975-81.
95. Yamagiwa H, Endo N, Tokunaga K, et al. In vivo bone-forming capacity of human bone marrow-derived stromal cells is stimulated by recombinant human bone morphogenetic protein-2. J Bone Minor Metab 2001; 19: 20-8.
96. Yen ML, Chien CC, Chiu IM, et al. Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells 2007; 25: 125-31.
97. Kim GS, Kim CH, Choi CS, Park JY, Lee KU. Involvement of different second messengers in parathyroid hormone- and interleukin-1-induced interleukin-6 and interleukin-11 production in human bone marrow stromal cells. J Bone Miner Res 1997; 12: 896-902.
98. Carpio L, Gladu J, Goltzman D, Rabbani SA. Induction of osteoblasst differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways. Am J Physiol Endocrinol Metab 2001; 281: E489-99.
99. Rickard DJ, Wang FL, Rodriguez-Rojas AM, et al. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 2006; 39(6): 1361-72.
100. Wu S, Palese T, Mishra OP, Delivoria-Papadopoulos M, De Luca F. Effects of Ca2+ sensing receptor activation in the growth plate. Faseb J 2004; 18: 143-5.
101. Tu Q, Pi M, Karsenty G, et al. Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest 2003; 111: 1029-37.
102. Bowler WB, Gallagher JA, Bilbe G. G-protein coupled receptors in bone. Front Biosci 1998; 3: d769-80.
103. House MG, Kohlmeier L, Chattopadhyay N, et al. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 1997; 12: 1959-70.
104. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-22.
105. Pacary E, Legros H, Valable S, et al. Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J Cell Sci 2006; 119: 2667-78.
106. Harmey D, Stenbeck G, Nobes CD, Lax AJ, Grigoriadis AE. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J Bone Miner Res 2004; 19: 661-70.
107. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004; 6: 483-95.
108. Meyers VE, Zayzafoon M, Douglas JT, McDonald JM. RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. J Bone Miner Res 2005; 20: 1858-66.
109. Lehmann M, Fournier A, Selles-Navarro I, et al. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 1999; 19: 7537-47.
110. Christakos S, Dhawan P, Liu Y, Peng X, Porta A. New insights into the mechanisms of vitamin D action. J Cell Biochem, 2003; 88: 695-705.
111. Clemens TL, Tang H, Maeda S, et al. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes. J Bone Miner Res 1997; 12: 1570-6.
112. Iris B, Zilberman Y, Zeira E, et al. Molecular imaging of the skeleton: quantitative real-time bioluminescence monitoring gene expression in bone repair and development. J Bone Miner Res 2003; 18: 570-8.
113. Chen J, Thomas HF, Sodek J. Regulation of bone sialoprotein and osteopontin mRNA expression by dexamethasone and 1,25-dihydroxyvitamin D3 in rat bone organ cultures. Connect Tissue Res 1996; 34: 41-51.
114. Thirunavukkarasu K, Halladay DL, Miles RR, et al. The osteolblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 2000; 275: 25163-72.
115. Maehata Y, Takamizawa S, Ozawa S, et al. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor. Matrix Biol 2006; 25: 47-58.
116. Kveiborg M, Flyvbjerg A, Eriksen EF, Kassem M. 1,25-Dihydroxyvitamin D3 stimulates the production of insulin-like growth factor-binding proteins-2, -3 and -4 in human bone marrow stromal cells. Eur J Endocrinol 2001; 144: 549-57.
117. De Kok IJ, Hicok KC, Padilla RJ, Young RG, Cooper LF. Effect of vitamm D pretreatment of human mesenchymal stem cells on ectopic bone formation. J Oral Implantol 2006; 32: 103-9.
118. Raffetto JD, Vasquez R, Goodwin DG, Menzoian JO. Mitogen-activated protein kinase pathway regulates cell proliferation in venous ulcer fibroblasts. Vasc Endovascular Surg 2006; 40: 59-66.
119. Tfelt-Hansen J, MacLeod RJ, Chattopadhyay N, et al. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells. Am J Physiol Endocrinol Metab 2003; 285: E329-37.
120. Lovicu FJ, McAvoy JW. FGF-induced lens cell proliferation and differentiation is dependent on MAPK (ERK1/2) signalling. Development 2001; 128: 5075-84.
121. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180-6.
122. Kato Y, Kravchenko VV, Tapping RI, et al. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. Embo J 1997; 16: 7054-66.
123. Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 1999; 274: 26563-71.
124. Jaiswal RK, Jaiswal N, Bruder SP, et al. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. JBiol Chem 2000; 275: 9645-52.
125. Radio NM, Doctor JS, Witt-Enderby PA. Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells gown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res 2006; 40: 332-42.
126. Simmons CA, Matlis S, Thornton AJ, et al. Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech 2003; 36: 1087-96.
127. Klees RF, Salasznyk RM, Kingsley K, et al. Laminin-5 induces osteogenic gene expression in human mesenchymal stem cells through an ERK-dependent pathway. Mol Biol Cell 2005; 16: 881-90.
128. Jadlowiec J, Koch H, Zhang X, et al. Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway. J Biol Chem 2004; 279: 53323-30.
129. Salasznyk RM, Klees RF, Hughlock MK, Plopper GE. ERK signaling pathways regulate the osteogenic differentiation of human mesenchymal stem cells on collagen I and vitronectin. Cell Commun Adhes 2004; 11: 137-53.
130. Gopalakrishnan R, Thomas PE, Benson MD, Wang D, Franceschi RT. A homeodomain protein binding element in the bone sialoprotein promoter is critical for tissue-specific expression in bone. Connect Tissue Res 2003; 44 (Suppl. 1): 154-60.